These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10105 related articles for article (PubMed ID: 12727113)

  • 21. Efficient responses in a murine renal tumor model by electroloading dendritic cells with whole-tumor lysate.
    Weiss JM; Allen C; Shivakumar R; Feller S; Li LH; Liu LN
    J Immunother; 2005; 28(6):542-50. PubMed ID: 16224271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy.
    Chen Z; Dehm S; Bonham K; Kamencic H; Juurlink B; Zhang X; Gordon JR; Xiang J
    Cell Immunol; 2001 Nov; 214(1):60-71. PubMed ID: 11902830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in mice.
    Minami T; Nakanishi Y; Izumi M; Harada T; Hara N
    J Immunother; 2003; 26(5):420-31. PubMed ID: 12973031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine.
    Orentas RJ; Schauer D; Bin Q; Johnson BD
    Cell Immunol; 2001 Oct; 213(1):4-13. PubMed ID: 11747351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
    Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
    J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas-deficient fully allogeneic dendritic cells administered via an intratumoral injection route show efficient antitumor effects in murine models.
    Okano S; Kondoh H; Toshima T; Nakagawara H; Yoshizumi T; Soejima Y; Shirabe K; Harada M; Yoshikai Y; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Jan; 104(1):15-26. PubMed ID: 23600321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer immunotherapy by fusions of dendritic cells and tumor cells.
    Koido S; Hara E; Homma S; Ohkusa T; Gong J; Tajiri H
    Immunotherapy; 2009 Jan; 1(1):49-62. PubMed ID: 20635973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine.
    Kao JY; Gong Y; Chen CM; Zheng QD; Chen JJ
    J Immunol; 2003 Apr; 170(7):3806-11. PubMed ID: 12646647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine.
    Kjaergaard J; Shimizu K; Shu S
    Cell Immunol; 2003 Oct; 225(2):65-74. PubMed ID: 14698141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
    Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
    Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
    Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
    Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
    J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity.
    Xia D; Li F; Xiang J
    Cancer Biother Radiopharm; 2004 Jun; 19(3):322-30. PubMed ID: 15285878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.
    Kim GY; Chae HJ; Kim KH; Yoon MS; Lee KS; Lee CM; Moon DO; Lee JS; Jeong YI; Choi YH; Park YM
    Biosci Biotechnol Biochem; 2007 Jan; 71(1):215-21. PubMed ID: 17213658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity.
    Mashino K; Sadanaga N; Tanaka F; Ohta M; Yamaguchi H; Mori M
    Mol Cancer Ther; 2002 Aug; 1(10):785-94. PubMed ID: 12492111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 506.